STOCK TITAN

Abacus Sells $50 Million of Securitized Life Insurance Assets to Institutional Investors

(Moderate)
(Very Positive)
Tags

Abacus (NASDAQ: ABL) sold $50 million of securitized life insurance assets in a transaction structured as an above investment-grade rated collateralized note. The deal closed on October 22, 2025 and carries a mid-single-digit yield. The structure is designed to give institutional investors, banks, and insurance companies direct, rated exposure to life insurance assets with reduced correlation to traditional markets and lower single-asset risk.

Loading...
Loading translation...

Positive

  • $50 million securitized life insurance assets sold
  • Transaction closed on October 22, 2025
  • Deal structured as an above investment-grade rated collateralized note
  • Note carries a mid-single-digit yield
  • Targets institutional investors, banks, and insurance companies

Negative

  • None.

News Market Reaction – ABL

-1.07%
3 alerts
-1.07% Session close to close
+12.0% Peak Tracked
$579.14M Market Cap
1.2x Rel. Volume

In the Oct 23 session, ABL declined 1.07%, reflecting a mild negative market reaction. Argus tracked a peak move of +12.0% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

~ Transaction Structured as an Above Investment Grade-Rated Collateralized Note ~ 

ORLANDO, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL), a leader in alternative asset management, announced that it successfully sold $50 million of securitized life insurance assets, the deal was structured as an above investment-grade rated collateralized note. The transaction closed on October 22, 2025. This innovative transaction enables institutional investors, banks, and insurance companies to gain direct exposure to life insurance assets via an uncorrelated rated structure.

The note carries an above investment-grade rating and a mid-single-digit yield. This demonstrates strong institutional demand for longevity-based assets that provide diversification from traditional market exposures, and mitigates risks associated with owning individual life settlement assets.

Jay Jackson, Chairman and Chief Executive Officer of Abacus, said, "This solution provides institutional investors with direct access to the uncorrelated investment opportunity of life insurance policies through an innovative, highly-rated, and securitized structure. This is a key milestone for our business and demonstrates our ability to create new institutional interest for life insurance assets.”

About Abacus
Abacus Global Management (NASDAQ: ABL) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.

For more information, please visit abacusgm.com.

Contacts:
Investor Relations
Robert F. Phillips – SVP Investor Relations and Corporate Affairs rob@abacusgm.com
(321) 290-1198

David Jackson – Managing Director of Investor Relations david@abacusgm.com
(321) 299-0716

Abacus Global Management Public Relations
press@abacusgm.com


FAQ

What did Abacus (ABL) sell on October 22, 2025?

Abacus sold $50 million of securitized life insurance assets via a rated collateralized note.

What rating and yield does the ABL collateralized note have?

The note is described as above investment-grade and carries a mid-single-digit yield.

Who can invest in the securitized life insurance note offered by ABL?

The structure is aimed at institutional investors, banks, and insurance companies seeking rated exposure.

When did the Abacus (ABL) transaction close?

The transaction closed on October 22, 2025.

How does Abacus (ABL) describe the investment exposure from this note?

Abacus says the structure offers direct, uncorrelated exposure to life insurance assets with mitigated individual-asset risk.

What significance did Abacus (ABL) attribute to the sale?

Abacus called the deal a key milestone demonstrating demand and its ability to create institutional interest in life insurance assets.